Relating to step therapy for nonopioids.

Senate order date changed from April 15 to June 19, with Senate amendments now dated April 15 and June 19.

Digest text was updated to remove references to OHP and state managed medical assistance, focusing only on health insurance providers.

New subsection added to ORS 414.361 requiring the Pharmacy and Therapeutics Committee to consider substantial cost differences among drugs within the same therapeutic class when making recommendations.

Added new definitions for 'clinically appropriate,' 'compendia,' and 'nonopioid prescription drug' to clarify what drugs qualify for coverage parity with opioids.

Added requirement that health care coverage entities must ensure their drug formularies include at least one clinically appropriate nonopioid drug as an alternative for each opioid drug.

Added requirement that the Pharmacy and Therapeutics Committee recommend nonopioid drug alternatives to opioids when making recommendations for preferred drug lists.

Added requirement that utilization review requirements and cost-sharing provisions for nonopioid drugs must match those for opioid drugs when treating the same condition.

Modified to explicitly include state managed medical assistance alongside health insurance providers as entities subject to coverage parity requirements.